Neuroimaging studies have just begun to explore the acute effects of psychedelics on large-scale brain networks’ functional organization. Even less is known about the neural correlates of subacute effects taking place days after the psychedelic experience. This study explores the subacute changes of primary sensory brain networks and networks supporting higher-order affective and self-referential functions 24 hours after a single session with the psychedelic ayahuasca.
Methods:
We leveraged task-free functional magnetic resonance imaging data 1 day before and 1 day after a randomized placebo-controlled trial exploring the effects of ayahuasca in naïve healthy participants (21 placebo/22 ayahuasca). We derived intra- and inter-network functional connectivity of the salience, default mode, visual, and sensorimotor networks, and assessed post-session connectivity changes between the ayahuasca and placebo groups. Connectivity changes were associated with Hallucinogen Rating Scale scores assessed during the acute effects.
Results:
Our findings revealed increased anterior cingulate cortex connectivity within the salience network, decreased posterior cingulate cortex connectivity within the default mode network, and increased connectivity between the salience and default mode networks 1 day after the session in the ayahuasca group compared to placebo. Connectivity of primary sensory networks did not differ between groups. Salience network connectivity increases correlated with altered somesthesia scores, decreased default mode network connectivity correlated with altered volition scores, and increased salience default mode network connectivity correlated with altered affect scores.
Conclusion:
These findings provide preliminary evidence for subacute functional changes induced by the psychedelic ayahuasca on higher-order cognitive brain networks that support interoceptive, affective, and self-referential functions.
AbdallahCGAverillLACollinsKA, et al. (2017) Ketamine treatment and global brain connectivity in major depression. Neuropsychopharmacology42: 1210–1219.
2.
AllenEAErhardtEBDamarajuE, et al. (2011) A baseline for the multivariate comparison of resting-state networks. Front Syst Neurosci5: 2.
3.
BarkerSA (2018) N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: Past, present, and future research to determine its role and function. Front Neurosci12: 536.
4.
BehzadiYRestomKLiauJ, et al. (2007) A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. NeuroImage37: 90–101.
5.
BeliveauVGanzMFengL, et al. (2017) A high-resolution in vivo atlas of the human brain’s serotonin system. J Neurosci37: 120–128.
6.
BermanMGPeltierSNeeDE, et al. (2011) Depression, rumination and the default network. Soc Cogn Affect Neurosci6: 548–555.
7.
BonhommeVVanhaudenhuyseADemertziA, et al. (2016) Resting-state network-specific breakdown of functional connectivity during ketamine alteration of consciousness in volunteers. Anesthesiology125: 873–888.
8.
BousoJCPalhano-FontesFRodríguez-FornellsA, et al. (2015) Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol25: 483–492.
9.
BrewerJGarrisonKWhitfield-GabrieliS (2013) What about the ‘self’ is processed in the posterior cingulate cortex?Front Hum Neurosci7: 647.
10.
BucknerRLAndrews-HannaJRSchacterDL (2008) The brain’s default network: Anatomy, function, and relevance to disease. Ann N Y Acad Sci1124: 1–38.
11.
CalhounVDAdaliTPearlsonG, et al. (2001) Group ICA of functional MRI data: Separability, stationarity, and inference. In: Proceedings of the International Conference on ICA and BSS, San Diego, CA, p. 155.
12.
Carhart-HarrisRLErritzoeDWilliamsT, et al. (2012) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci USA109: 2138–2143.
13.
Carhart-HarrisRLLeechRErritzoeD, et al. (2013) Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophr Bull39: 1343–1351.
14.
Carhart-HarrisRLBolstridgeMRuckerJ, et al. (2016a) Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. Lancet Psychiatry3: 619–627.
15.
Carhart-HarrisRLMuthukumaraswamySRosemanL, et al. (2016b) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci USA113: 4853–4858.
16.
Carhart-HarrisRLRosemanLBolstridgeM, et al. (2017) Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms. Sci Rep7: 13187.
17.
CraigADB (2009) How do you feel–now? The anterior insula and human awareness. Nat Rev Neurosci10: 59–70.
18.
CritchleyHDHarrisonNA (2013) Visceral influences on brain and behavior. Neuron77: 624–638.
19.
De AraujoDBRibeiroSCecchiGA, et al. (2012) Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion. Hum Brain Mapp33: 2550–2560.
20.
Dos SantosRGBalthazarFMBousoJC, et al. (2016) The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. J Psychopharmacol30: 1230–1247.
21.
Dos SantosRGHallakJEC (2020) Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms. Neurosci Biobehav Rev108: 423–434.
22.
EklundANicholsTEKnutssonH (2016) Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates. Proc Natl Acad Sci USA113: 7900–7905.
23.
EtkinAEgnerTKalischR (2011) Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci15: 85–93.
24.
FanLLiHZhuoJ, et al. (2016) The human brainnetome atlas: A new brain atlas based on connectional architecture. Cereb Cortex26: 3508–3526.
25.
FontanillaDJohannessenMHajipourAR, et al. (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science323: 934–937.
26.
FoxMDSnyderAZVincentJL, et al. (2005) The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA102: 9673–9678.
27.
FredericksCASturmVEBrownJA, et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer’s disease. Alzheimers Dement (Amst)10: 471–479.
28.
GoodmanN (2002) The serotonergic system and mysticism: Could LSD and the nondrug-induced mystical experience share common neural mechanisms?J Psychoactive Drugs34: 263–272.
29.
GorgolewskiKJVaroquauxGRiveraG, et al. (2015) NeuroVault.org: A web-based repository for collecting and sharing unthresholded statistical maps of the human brain. Front Neuroinform9: 8.
30.
GraysonDSFairDA (2017) Development of large-scale functional networks from birth to adulthood: A guide to the neuroimaging literature. Neuroimage160: 15–31.
31.
GreiciusMDFloresBHMenonV, et al. (2007) Resting-state functional connectivity in major depression: Abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry62: 429–437.
32.
GriffithsRRJohnsonMWCarducciMA, et al. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol30: 1181–1197.
33.
GriffithsRRJohnsonMWRichardsWA, et al. (2011) Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology218: 649–665.
34.
GrobCSDanforthALChopraGS, et al. (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry68: 71.
35.
HolzeFVizeliPMüllerF, et al. (2020) Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. Neuropsychopharmacol45: 462–471.
36.
IonescuDFFelicioneJMGosaiA, et al. (2018) Ketamine-associated brain changes: a review of the neuroimaging literature. Harv Rev Psychiatry26: 320–339.
LebedevAVLövdénMRosenthalG, et al. (2015) Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. Hum Brain Mapp36: 3137–3153.
39.
LehmannMSeifritzEHenningA, et al. (2016) Differential effects of rumination and distraction on ketamine induced modulation of resting state functional connectivity and reactivity of regions within the default-mode network. Soc Cogn Affect Neurosci11: 1227–1235.
40.
LyversMMeesterM (2012) Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. J Psychoactive Drugs44: 410–417.
41.
MajićTSchmidtTTGallinatJ (2015) Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?J Psychopharmacol29(3): 241–253.
42.
MckennaDJTowersGHNAbbottF (1984) Monoamine-oxidase inhibitors in South-American hallucinogenic plants - tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol10: 195–223.
43.
MenonVUddinLQ (2010) Saliency, switching, attention and control: A network model of insula function. Brain Struct Funct214: 655–667.
44.
MizumotoSda SilveiraDXBarbosaPCR, et al. (2011) Hallucinogen Rating Scale ( HRS ) – Versão brasileira : tradução e adaptação transcultural Hallucinogen Rating Scale ( HRS ) – A Brazilian version: Translation and cross-cultural adaptation. Rev Psiq Clín38(6): 231–237.
OchsnerKNGrossJJ (2005) The cognitive control of emotion. Trends Cogn Sci9: 242–249.
47.
Osório F deLSanchesRFMacedoLR, et al. (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report. Braz J Psychiatry37: 13–20.
48.
Palhano-FontesFAndradeKCTofoliLF, et al. (2015) The psychedelic state induced by Ayahuasca modulates the activity and connectivity of the Default Mode Network. PLoS One10: e0118143.
49.
Palhano-FontesFBarretoDOniasH, et al. (2019) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychol Med49: 655–663.
50.
ParkesLFulcherBYücelM, et al. (2018) An evaluation of the efficacy, reliability, and sensitivity of motion correction strategies for resting-state functional MRI. NeuroImage171: 415–436.
51.
PasquiniLNanaALTollerG, et al. (2019a) Salience network atrophy links neuron type-specific degeneration to loss of empathy in frontotemporal dementia. bioRxiv. Available at: https://www.biorxiv.org/content/10.1101/691212v2.abstract.
52.
PasquiniLScherrMTahmasianM, et al. (2015) Link between hippocampus’ raised local and eased global intrinsic connectivity in AD. Alzheimers Dement11: 475–484.
53.
PasquiniLTollerGStaffaroniA, et al. (2019b) State and trait characteristics of anterior insula time-varying functional connectivity. NeuroImage208: 116425.
54.
PetriGExpertPTurkheimerF, et al. (2014) Homological scaffolds of brain functional networks. J Royal Society11: 20140873.
55.
PowerJDBarnesKASnyderAZ, et al. (2012) Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. NeuroImage59: 2142–2154.
56.
PowerJDMitraALaumannTO, et al. (2014) Methods to detect, characterize, and remove motion artifact in resting state fMRI. NeuroImage84: 320–341.
57.
RaichleME (2015) The brain’s default mode network. Ann Rev Neurosci38: 433–447.
58.
RaichleMEMacLeodAMSnyderAZ, et al. (2001) A default mode of brain function. Proc Natl Acad Sci USA98: 676–682.
59.
RankinKPGorno-TempiniMLAllisonSC, et al. (2006) Structural anatomy of empathy in neurodegenerative disease. Brain129: 2945–2956.
60.
RibaJRodrıAStrassmanRJ, et al. (2001a) Psychometric assessment of the hallucinogen rating scale. Drug Alcohol Depend62: 215–223.
61.
RibaJRodríguez-FornellsAUrbanoG, et al. (2001b) Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology154: 85–95.
62.
RibaJAndererPJanéF, et al. (2004) Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: A functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology50: 89–101.
63.
RosemanLLeechRFeildingA, et al. (2014) The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers. Front Hum Neurosci8: 204.
64.
RossSBossisAGussJ, et al. (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J Psychopharmacol30: 1165–1180.
65.
SampedroFde la Fuente RevengaMValleM, et al. (2017) Assessing the psychedelic ‘ after-glow ’ in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. Int J Neuropsychopharmacol20: 698–711.
66.
SanchesRFde Lima OsórioFDos SantosRG, et al. (2016) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study. J Clin Psychopharmacol36: 77–81.
67.
SatterthwaiteTDElliottMAGerratyRT, et al. (2013) An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data. NeuroImage64: 240–256.
68.
SatterthwaiteTDWolfDHLougheadJ, et al. (2012) Impact of in-scanner head motion on multiple measures of functional connectivity: Relevance for studies of neurodevelopment in youth. NeuroImage60: 623–632.
69.
ScheideggerMWalterMLehmannM, et al. (2012) Ketamine decreases resting state functional network connectivity in healthy subjects: Implications for antidepressant drug action. PLoS One7: e44799.
70.
SeeleyWWMenonVSchatzbergAF, et al. (2007) Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci27: 2349–2356.
71.
SeeleyWWZhouJKimE-J (2012) Frontotemporal dementia: What can the behavioral variant teach us about human brain organization?Neuroscientist18: 373–385.
72.
ShelineYIBarchDMPriceJL, et al. (2009) The default mode network and self-referential processes in depression. Proc Natl Acad Sci USA106: 1942–1947.
73.
SikoraMHeffernanJAveryET, et al. (2016) Salience network functional connectivity predicts placebo effects in major depression. Biol Psychiatry Cogn Neurosci Neuroimaging1: 68–76.
74.
SmithSMNicholsTE (2009) Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage44: 83–98.
75.
SmithSMFoxPTMillerKL, et al. (2009) Correspondence of the brain’s functional architecture during activation and rest. Proc Natl Acad Sci USA106: 13040–13045.
76.
StrassmanRJQuallsCRUhlenhuthEH, et al. (1994) Dose-response study of N,N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry51: 98–108.
77.
SturmVEYokoyamaJSSeeleyWW, et al. (2013) Heightened emotional contagion in mild cognitive impairment and Alzheimer’s disease is associated with temporal lobe degeneration. Proc Natl Acad Sci USA110: 9944–9949.
78.
SturmVEBrownJAHuaAY, et al. (2018a) Network architecture underlying basal autonomic outflow: Evidence from frontotemporal dementia. J Neurosci38: 8943–8955.
79.
SturmVESibleIJDattaS, et al. (2018b) Resting parasympathetic dysfunction predicts prosocial helping deficits in behavioral variant frontotemporal dementia. Cortex109: 141–155.
80.
TagliazucchiERosemanLKaelenM, et al. (2016) Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr Biol26: 1043–1050.
81.
TouroutoglouAHollenbeckMDickersonBC, et al. (2012) Dissociable large-scale networks anchored in the right anterior insula subserve affective experience and attention. NeuroImage60: 1947–1958.
82.
TrichterSKlimoJKrippnerS (2009) Changes in spirituality among ayahuasca ceremony novice participants. J Psychoact Drugs41: 121–134.
83.
UddinLQ (2015) Salience processing and insular cortical function and dysfunction. Nature Rev Neurosci16: 55–61.
84.
van den HeuvelMPHulshoff PolHE (2010) Exploring the brain network: A review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol20: 519–534.
85.
ViolAPalhano-FontesFOniasH, et al. (2017) Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca. Sci Rep7: 7388.
86.
ViolAPalhano-FontesFOniasH, et al. (2019) Characterizing complex networks using Entropy-degree diagrams: Unveiling changes in functional brain connectivity induced by Ayahuasca. Entropy. Available at: https://www.mdpi.com/1099-4300/21/2/128.
87.
VollenweiderFXLeendersKLScharfetterC, et al. (1997) Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology16: 357–372.
88.
WagerTDRillingJKSmithEE, et al. (2004) Placebo-induced changes in FMRI in the anticipation and experience of pain. Science303: 1162–1167.
89.
Whitfield-GabrieliSNieto-CastanonA (2012) Conn: A functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect2: 125–141.
90.
WilliamsLM (2016) Precision psychiatry: A neural circuit taxonomy for depression and anxiety. Lancet Psychiatry3: 472–480.
91.
WinklerAMRidgwayGRWebsterMA, et al. (2014) Permutation inference for the general linear model. NeuroImage92: 381–397.
92.
YanC-GChenXLiL, et al. (2019) Reduced default mode network functional connectivity in patients with recurrent major depressive disorder. Proc Natl Acad Sci USA116: 9078–9083.
93.
ZhouJSeeleyWW (2014) Network dysfunction in Alzheimer’s disease and frontotemporal dementia: Implications for psychiatry. Biol Psychiatry75: 565–573.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
